{"@context":{"@vocab":"https://schema.org/","scidex":"https://scidex.ai/vocab/"},"@type":"Dataset","name":"Bibliography — APOE4-Specific Proteolytic Fragment Inhibition Therapy","about":{"@type":"CreativeWork","identifier":"h-var-600b3e39aa"},"generatedAt":"2026-04-28T10:33:16Z","@graph":[{"@type":"ScholarlyArticle","identifier":"40149001","name":"Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.","author":"Jung ES, Choi H, Mook-Jung I","isPartOf":{"@type":"Periodical","name":"Molecular neurodegeneration"},"datePublished":"2025","url":"https://pubmed.ncbi.nlm.nih.gov/40149001/"},{"@type":"ScholarlyArticle","identifier":"39232848","name":"Updates in Alzheimer's disease: from basic research to diagnosis and therapies.","author":"Liu E, Zhang Y, Wang JZ","isPartOf":{"@type":"Periodical","name":"Translational neurodegeneration"},"datePublished":"2024","url":"https://pubmed.ncbi.nlm.nih.gov/39232848/"},{"@type":"ScholarlyArticle","identifier":"39232848","name":"Updates in Alzheimer's disease: from basic research to diagnosis and therapies.","author":"Liu E, Zhang Y, Wang JZ","isPartOf":{"@type":"Periodical","name":"Transl Neurodegener"},"datePublished":"2024","url":"https://pubmed.ncbi.nlm.nih.gov/39232848/"},{"@type":"ScholarlyArticle","identifier":"35232622","name":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.","author":"Parhizkar S, Holtzman DM","isPartOf":{"@type":"Periodical","name":"Seminars in immunology"},"datePublished":"2022","url":"https://pubmed.ncbi.nlm.nih.gov/35232622/"},{"@type":"ScholarlyArticle","identifier":"33958804","name":"Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease.","author":"Zalocusky KA, Najm R, Taubes AL, Hao Y, Yoon SY, Koutsodendris N, Nelson MR, Rao A, Bennett DA, Bant J, Amornkul DJ, Xu Q, An A, Cisne-Thomson O, Huang Y","isPartOf":{"@type":"Periodical","name":"Nature neuroscience"},"datePublished":"2021","url":"https://pubmed.ncbi.nlm.nih.gov/33958804/"}]}